Advertisement

Activation-Induced Cell Death of T Cells in Human Aging

  • Ewa Sikora
  • Agnieszka Brzezińska
Living reference work entry

Abstract

The elimination of expanded T cells at the end of immune response is crucial to maintain homeostasis and avoid any uncontrolled inflammation. Resting mature T lymphocytes when activated via their antigen-specific receptor (TCR) and CD28 coreceptor start to proliferate and acquire resistance to apoptosis. Reactivation of T cells induces expression of CD95L, which after binding to CD95 surface-expressed death receptor, triggers signaling pathway to apoptosis. The process is called activation-induced cell death (AICD). In executing AICD, receptor-dependent apoptotic pathway overlaps with mitochondrial signaling to apoptosis. Immunosenescence leads to the shrinkage of T-cell repertoire due to the reduction of naïve cells and accumulation of oligoclonal CD8+ and, to a lower extent, CD4+ cells, which are mainly CD95-positive and CD28-negative. CD28− cells dominate not only in elderly people, but their presence has also been linked to autoimmune disease, AIDS, and age-related disorders or decreased efficacy of vaccination. Propensity of CD28− cells to undergo AICD, and generally, apoptosis changes with age. However, collected data so far are inconclusive as they show an increased, unchanged, or decreased propensity to apoptosis in the elderly in comparison with young individuals. Recently, a definite involvement of autophagy and necroptosis in homeostasis of T cells has been recognized; however, their role in the termination of the adaptive immune response is still poorly known, especially in aging. However, it can be expected that future studies on necroptotic and autophagic cell death will clarify the so far inconsistent data concerning age-dependent changes in AICD.

Keywords

Apoptosis Autophagy CD28 CD95 Necroptosis 

Notes

Acknowledgment

It is to acknowledge that the part of this chapter was already published in Elsevier Journal as the following article by Ewa Sikora (2015).

References

  1. Aggarwal S, Gupta S (1998) Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 160(4):1627–1637PubMedGoogle Scholar
  2. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV (1999) Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol 162(9):5205–5211PubMedGoogle Scholar
  3. Arnold R, Brenner D, Becker M, Frey CR, Krammer PH (2006) How T lymphocytes switch between life and death. Eur J Immunol 36(7):1654–1658CrossRefPubMedGoogle Scholar
  4. Arnold CR, Pritz T, Brunner S, Knabb C, Salvenmoser W, Holzwarth B, Thedieck K, Grubeck-Loebenstein BT (2014) Cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(−) T cells. Exp Gerontol 54:75–83CrossRefPubMedGoogle Scholar
  5. Bell BD, Leverrier S, Weist BM, Newton RH, Arechiga AF, Luhrs KA, Morrissette NS, Walsh CM (2008) FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci USA 105(43):16677–16682CrossRefPubMedPubMedCentralGoogle Scholar
  6. Brenner D, Golks A, Kiefer F, Krammer PH, Arnold R (2005) Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. EMBO J 24(24):4279–4290CrossRefPubMedPubMedCentralGoogle Scholar
  7. Brenner D, Krammer PH, Arnold R (2008) Concepts of activated T cell death. Crit Rev Oncol Hematol 66(1):52–64CrossRefPubMedGoogle Scholar
  8. Brzezinska A (2005) Does in vitro replicative senescence of human CD8+ cells reflect the phenotypic changes observed during in vivo ageing? Acta Biochim Pol 52(4):931–935PubMedGoogle Scholar
  9. Brzezinska A, Magalska A, Sikora E (2003) Proliferation of CD8+ in culture of human T cells derived from peripheral blood of adult donors and cord blood of newborns. Mech Ageing Dev 124(4):379–387CrossRefPubMedGoogle Scholar
  10. Brzezinska A, Magalska A, Szybinska A, Sikora E (2004) Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(−) lymphocytes during aging. Exp Gerontol 39(4):539–544CrossRefPubMedGoogle Scholar
  11. Cao W, Mehraj V, Kaufmann DE, Li T, Routy JP (2016) Elevation and persistence of CD8 T-cells in HIV infection: the Achilles heel in the ART era. J Int AIDS Soc 19(1):20697.  https://doi.org/10.7448/IAS.19.1.20697CrossRefPubMedPubMedCentralGoogle Scholar
  12. Capri M, Monti D, Salvioli S, Lescai F, Pierini M, Altilia S, Sevini F, Valensin S, Ostan R, Bucci L, Franceschi C (2006) Complexity of anti-immunosenescence strategies in humans. Artif Organs 30(10):730–742CrossRefPubMedGoogle Scholar
  13. Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB (2009) Vaccination in the elderly: an immunological perspective. Trends Immunol 30(7):351–359CrossRefPubMedPubMedCentralGoogle Scholar
  14. Ch'en IL, Beisner DR, Degterev A, Lynch C, Yuan J, Hoffmann A, Hedrick SM (2008) Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci USA 105(45):17463–17468CrossRefPubMedPubMedCentralGoogle Scholar
  15. Ch'en IL, Tsau JS, Molkentin JD, Komatsu M, Hedrick SM (2011) Mechanisms of necroptosis in T cells. J Exp Med 208(4):633–641CrossRefPubMedPubMedCentralGoogle Scholar
  16. Christofferson DE, Yuan J (2010) Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol 22(2):263–268CrossRefPubMedPubMedCentralGoogle Scholar
  17. Dejaco C, Duftner C, Klauser A, Schirmer M (2010) Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica. Rheumatol Int 30(3):297–303CrossRefPubMedGoogle Scholar
  18. Dennett NS, Barcia RN, McLeod JD (2002) Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Exp Gerontol 37(2-3):271–283CrossRefPubMedGoogle Scholar
  19. Donnini A, Re F, Bollettini M, Moresi R, Tesei S, Bernardini G, Provinciali M (2005) Age-related susceptibility of naive and memory CD4 T cells to apoptosis induced by IL-2 deprivation or PHA addition. Biogerontology 6(3):193–204CrossRefPubMedGoogle Scholar
  20. Dunkle A, He YW (2011) Apoptosis and autophagy in the regulation of T lymphocyte function. Immunol Res 49(1-3):70–86CrossRefPubMedPubMedCentralGoogle Scholar
  21. Effros RB, Dagarag M, Spaulding C, Man J (2005) The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 205:147–157CrossRefPubMedGoogle Scholar
  22. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, Casti A, Franceschi C, Passeri M, Sansoni P (2000) Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 95(9):2860–2868PubMedGoogle Scholar
  23. Gerland LM, Genestier L, Peyrol S, Michallet MC, Hayette S, Urbanowicz I, Ffrench P, Magaud JP, Ffrench M (2004) Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells. Exp Gerontol 39(5):789–800CrossRefPubMedGoogle Scholar
  24. Ginaldi L, De Martinis M, Monti D, Franceschi C (2004) The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol Res 30(1):81–94CrossRefPubMedGoogle Scholar
  25. Green DR, Droin N, Pinkoski M (2003) Activation-induced cell death in T cells. Immunol Rev 193:70–81CrossRefPubMedGoogle Scholar
  26. Gupta S (2005) Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev 205:114–129CrossRefPubMedGoogle Scholar
  27. Gupta S, Gollapudi S (2006) Molecular mechanisms of TNF-alpha-induced apoptosis in naive and memory T cell subsets. Autoimmun Rev 5(4):264–268CrossRefPubMedGoogle Scholar
  28. Herndon FJ, Hsu HC, Mountz JD (1997) Increased apoptosis of CD45RO- T cells with aging. Mech Ageing Dev 94(1-3):123–134CrossRefPubMedGoogle Scholar
  29. Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P (2002) Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 14(3):354–359CrossRefPubMedGoogle Scholar
  30. Hsu HC, Scott DK, Mountz JD (2005) Impaired apoptosis and immune senescence – cause or effect? Immunol Rev 205:130–146CrossRefPubMedGoogle Scholar
  31. Hubbard VM, Valdor R, Patel B, Singh R, Cuervo AM, Macian F (2010) Macroautophagy regulates energy metabolism during effector T cell activation. J Immunol 185(12):7349–7357CrossRefPubMedPubMedCentralGoogle Scholar
  32. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388(6638):190–195CrossRefPubMedGoogle Scholar
  33. Jacobson MD, Weil M, Raff MC (1997) Programmed cell death in animal development. Cell 88(3):347–354CrossRefPubMedGoogle Scholar
  34. Jia W, Pua HH, Li QJ, He YW (2011) Autophagy regulates endoplasmic reticulum homeostasis and calcium mobilization in T lymphocytes. J Immunol 186(3):1564–1574CrossRefPubMedGoogle Scholar
  35. Kabelitz D, Janssen O (1997) Antigen-induced death of T-lymphocytes. Front Biosci 2:d61–d77CrossRefPubMedGoogle Scholar
  36. Kang C, Elledge SJ (2016) How autophagy both activates and inhibits cellular senescence. Autophagy 12(5):898–899CrossRefPubMedPubMedCentralGoogle Scholar
  37. Kirchhoff S, Muller WW, Li-Weber M, Krammer PH (2000) Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur J Immunol 30(10):2765–2774CrossRefPubMedGoogle Scholar
  38. Klas C, Debatin KM, Jonker RR, Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5(6):625–630CrossRefPubMedGoogle Scholar
  39. Krammer PH (2000) CD95’s deadly mission in the immune system. Nature 407(6805):789–795CrossRefPubMedGoogle Scholar
  40. Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7(7):532–542CrossRefPubMedGoogle Scholar
  41. Larbi A, Muti E, Giacconi R, Mocchegiani E, Fulop T (2006) Role of lipid rafts in activation-induced cell death: the fas pathway in aging. Adv Exp Med Biol 584:137–155CrossRefPubMedGoogle Scholar
  42. Lechner H, Amort M, Steger MM, Maczek C, Grubeck-Loebenstein B (1996) Regulation of CD95 (APO-1) expression and the induction of apoptosis in human T cells: changes in old age. Int Arch Allergy Immunol 110(3):238–243CrossRefPubMedGoogle Scholar
  43. Li H, Manwani B, Leng SX (2011) Frailty, inflammation, and immunity. Aging Dis 2(6):466–473PubMedPubMedCentralGoogle Scholar
  44. Lu B, Finn OJ (2008) T-cell death and cancer immune tolerance. Cell Death Differ 15(1):70–79CrossRefPubMedGoogle Scholar
  45. Lu JV, Walsh CM (2012) Programmed necrosis and autophagy in immune function. Immunol Rev 249(1):205–217CrossRefPubMedPubMedCentralGoogle Scholar
  46. Lu JV, Chen HC, Walsh CM (2014) Necroptotic signaling in adaptive and innate immunity. Semin Cell Dev Biol 35:33–39CrossRefPubMedGoogle Scholar
  47. Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA (2013) Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 208(4):564–572CrossRefPubMedPubMedCentralGoogle Scholar
  48. Ma D, Yu H, Lin D, Sun Y, Liu L, Liu Y, Dai B, Chen W, Cao J (2009) S6K1 is involved in polyploidization through its phosphorylation at Thr421/Ser424. J Cell Physiol 219(1):31–44CrossRefPubMedGoogle Scholar
  49. Marino G, Niso-Santano M, Baehrecke EH, Kroemer G (2014) Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol 15(2):81–94CrossRefPubMedPubMedCentralGoogle Scholar
  50. Martinez-Lopez N, Athonvarangkul D, Singh R (2015) Autophagy and aging. Adv Exp Med Biol 847:73–87CrossRefPubMedPubMedCentralGoogle Scholar
  51. McLeod JD, Walker LS, Patel YI, Boulougouris G, Sansom DM (1998) Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J Immunol 160(5):2072–2079PubMedGoogle Scholar
  52. Mizushima N, Ohsumi Y, Yoshimori T (2002) Autophagosome formation in mammalian cells. Cell Struct Funct 27(6):421–429CrossRefPubMedGoogle Scholar
  53. Muppidi JR, Siegel RM (2004) Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol 5(2):182–189CrossRefPubMedGoogle Scholar
  54. Osborne BA (1996) Apoptosis and the maintenance of homoeostasis in the immune system. Curr Opin Immunol 8(2):245–254CrossRefPubMedGoogle Scholar
  55. Pallis AG, Hatse S, Brouwers B, Pawelec G, Falandry C, Wedding U, Lago LD, Repetto L, Ring A, Wildiers H (2014) Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging? J Geriatric Oncol 5(2):204–218CrossRefGoogle Scholar
  56. Palmer E (2003) Negative selection–clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol 3(5):383–391CrossRefPubMedGoogle Scholar
  57. Pasparakis M, Vandenabeele P (2015) Necroptosis and its role in inflammation. Nature 517(7534):311–320CrossRefPubMedGoogle Scholar
  58. Pawelec G (2014) Immunosenenescence: role of cytomegalovirus. Exp Gerontol 54:1–5CrossRefPubMedGoogle Scholar
  59. Pawelec G, Sansom D, Rehbein A, Adibzadeh M, Beckman I (1996) Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+ TCR2+ cultured T cell clones. Exp Gerontol 31(6):655–668CrossRefPubMedGoogle Scholar
  60. Pawelec G, Goldeck D, Derhovanessian E (2014) Inflammation, ageing and chronic disease. Curr Opin Immunol 29:23–28CrossRefPubMedGoogle Scholar
  61. Phelouzat MA, Arbogast A, Laforge T, Quadri RA, Proust JJ (1996) Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 88(1-2):25–38CrossRefPubMedGoogle Scholar
  62. Phelouzat MA, Laforge T, Arbogast A, Quadri RA, Boutet S, Proust JJ (1997) Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors. Mech Ageing Dev 96(1-3):35–46CrossRefPubMedGoogle Scholar
  63. Pinti M, Troiano L, Nasi M, Bellodi C, Ferraresi R, Mussi C, Salvioli G, Cossarizza A (2004) Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century. Circulation 110(19):3108–3114CrossRefPubMedGoogle Scholar
  64. Posnett DN, Edinger JW, Manavalan JS, Irwin C, Marodon G (1999) Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28− cytotoxic effector clones. Int Immunol 11(2):229–241CrossRefPubMedGoogle Scholar
  65. Potestio M, Caruso C, Gervasi F, Scialabba G, D'Anna C, Di Lorenzo G, Balistreri CR, Candore G, Romano GC (1998) Apoptosis and ageing. Mech Ageing Dev 102(23):221–237CrossRefPubMedGoogle Scholar
  66. Potestio M, Pawelec G, Di Lorenzo G, Candore G, D'Anna C, Gervasi F, Lio D, Tranchida G, Caruso C, Romano GC (1999) Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp Gerontol 34(5):659–673CrossRefPubMedGoogle Scholar
  67. Prado-Garcia H, Romero-Garcia S, Aguilar-Cazares D, Meneses-Flores M, Lopez-Gonzalez JS (2012) Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Clin Develop Immunol 2012:741741CrossRefGoogle Scholar
  68. Pua HH, Dzhagalov I, Chuck M, Mizushima N, He YW (2007) A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 204(1):25–31CrossRefPubMedPubMedCentralGoogle Scholar
  69. Schindowski K, Leutner S, Muller WE, Eckert A (2000) Age-related changes of apoptotic cell death in human lymphocytes. Neurobiol Aging 21(5):661–670CrossRefPubMedGoogle Scholar
  70. Schmitz I, Krueger A, Baumann S, Schulze-Bergkamen H, Krammer PH, Kirchhoff S (2003) An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J Immunol 171(6):2930–2936CrossRefPubMedGoogle Scholar
  71. Semba RD, Margolick JB, Leng S, Walston J, Ricks MO, Fried LP (2005) T cell subsets and mortality in older community-dwelling women. Exp Gerontol 40(1-2):81–87CrossRefPubMedGoogle Scholar
  72. Shi YF, Sahai BM, Green DR (1989) Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339(6226):625–626CrossRefPubMedGoogle Scholar
  73. Sikora E (2013) Rejuvenation of senescent cells-the road to postponing human aging and age-related disease? Exp Gerontol 48(7):661–666CrossRefPubMedGoogle Scholar
  74. Sikora E (2015) Activation-induced and damage-induced cell death in aging human T cells. Mech Ageing Dev 151:85–92CrossRefPubMedGoogle Scholar
  75. Spaulding C, Guo W, Effros RB (1999) Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 34(5):633–644CrossRefPubMedGoogle Scholar
  76. Sprent J, Tough DF (2001) T cell death and memory. Science 293(5528):245–248CrossRefPubMedGoogle Scholar
  77. Strasser A, Pellegrini M (2004) T-lymphocyte death during shutdown of an immune response. Trends Immunol 25(11):610–615CrossRefPubMedGoogle Scholar
  78. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267(5203):1456–1462CrossRefPubMedGoogle Scholar
  79. Vallejo AN (2005) CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 205:158–169CrossRefPubMedGoogle Scholar
  80. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ (2000) Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J Immunol 165(11):6301–6307CrossRefPubMedGoogle Scholar
  81. Vanlangenakker N, Vanden Berghe T, Vandenabeele P (2012) Many stimuli pull the necrotic trigger, an overview. Cell Death Differ 19(1):75–86CrossRefPubMedGoogle Scholar
  82. Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G (2007) Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing 4:2CrossRefPubMedPubMedCentralGoogle Scholar
  83. Walker LS, McLeod JD, Boulougouris G, Patel YI, Hall ND, Sansom DM (1998) Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunology 94(1):41–47CrossRefPubMedPubMedCentralGoogle Scholar
  84. Widlak P, Garrard WT (2005) Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G. J Cell Biochem 94(6):1078–1087CrossRefPubMedGoogle Scholar
  85. Wikby A, Ferguson F, Forsey R, Thompson J, Strindhall J, Lofgren S, Nilsson BO, Ernerudh J, Pawelec G, Johansson B (2005) An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 60(5):556–565CrossRefPubMedGoogle Scholar
  86. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284(5756):555–556CrossRefPubMedGoogle Scholar
  87. Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, Di Pede P, Passeri G, Pedrazzoni M, Passeri M, Franceschi C, Sansoni P (2003) Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol 38(9):981–987CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Laboratory of the Molecular Bases of Ageing, Nencki Institute of Experimental BiologyPolish Academy of SciencesWarsawPoland

Personalised recommendations